Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...

As compared to controls, elevated nasal levels of ACE2 and TMPRSS2 were associated with a 3.6-fold increased risk of SARS-CoV ...